Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Other Non-Current Liabilities: 2021-2022

Historic Other Non-Current Liabilities for ADC Therapeutics (ADCT) over the last 2 years, with Dec 2022 value amounting to $838,000.

  • ADC Therapeutics' Other Non-Current Liabilities rose 46.61% to $305.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $305.3 million, marking a year-over-year increase of 46.61%. This contributed to the annual value of $838,000 for FY2022, which is 99.62% down from last year.
  • Per ADC Therapeutics' latest filing, its Other Non-Current Liabilities stood at $838,000 for FY2022, which was down 99.62% from $218.7 million recorded in FY2021.
  • ADC Therapeutics' 5-year Other Non-Current Liabilities high stood at $218.7 million for FY2021, and its period low was $838,000 during FY2022.
  • For the 2-year period, ADC Therapeutics' Other Non-Current Liabilities averaged around $109.8 million, with its median value being $109.8 million (2021).
  • Data for ADC Therapeutics' Other Non-Current Liabilities shows a maximum YoY slumped of 99.62% (in 2022) over the last 5 years.
  • Yearly analysis of 2 years shows ADC Therapeutics' Other Non-Current Liabilities stood at $218.7 million in 2021, then tumbled by 99.62% to $838,000 in 2022.